Dr. Robert Wolff, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Albany Medical College

  Medical School, 1986

• Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing, 2014-02-21

• Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay, 2015-12-21

• The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis, 2011-08-18

• Impact of Integrating IGF-1 Levels Into MELD Score for Survival Prediction in Hepatocellular Carcinoma Patients, 2020-10-07

• Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma, 2016-08-22

• Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer, 2019-08-23

• FBXW7missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma, 2017-04-05

• Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer?: A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab, 2014-03-04

• Pancreatic Intraepithelial Neoplasia and Histologic Changes in Non-neoplastic Pancreas Associated with Neoadjuvant Therapy in Patients with Pancreatic Ductal Adenocarcinoma, 2013-09-20

• PIK3CA/PTEN Mutations and Akt Activation as Markers of Sensitivity to Allosteric mTOR inhibitors, 2012-03-15

• Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival, 2021-04-01

• A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma, 2018-08-06

• Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines, 2012-06-01

• Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer, 2016-06-23

• Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection, 2012-05-30

• Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma, 2017-02-10

• HER2/neu-directed therapy for biliary tract cancer, 2015-05-29

• Origin and role of hepatic myofibroblasts in hepatocellular carcinoma, 2020-03-31

• Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients, 2021-07-11

• Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma, 2018-05-30

• Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction, 2015-12-29

• Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma, 2020-11-14

• Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer, 2014-10-29

• PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer, 2022-01-03

• Survival improvement for patients with metastatic colorectal cancer over twenty years, 2023-02-13

• Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma, 2018-12-28

• Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience, 2017-08-03

• Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy, 2023-06-18

• Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery, 2017-05-15

• Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma, 2016-09-16

• Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma, 2017-06-01

• Bintrafusp Alfa, an Anti-PD-L1:TGFß Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer, 2022-09-14

• Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer, 2022-10-14

• Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy, 2017-11-09

• Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer, 2017-03-07

• Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma, 2019-08-13

• Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma, 2019-12-27

• Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy, 2023-05-04

• Phase I Clinical Trial of Lenalidomide in Combination with Sorafenib in Patients with Advanced Cancer, 2013-06-12

• Impact ofKRASMutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma, 2023-08-10

• A High Lymph Node Ratio is Associated with Distant Recurrence After Surgical Resection of Ampullary Carcinoma, 2012-08-23

• Clinical utility of circulating cell-free DNA in advanced colorectal cancer, 2017-08-29

• Target-Based Therapeutic Matching in Early-Phase Clinical Trials in Patients with Advanced Colorectal Cancer andPIK3CAmutations, 2013-10-03

• Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology, 2011-04-12

• Modified FOLFIRINOX in Pancreatic Cancer Patients Age 75 or Older, 2020-01-09

• Bintrafusp alfa, an anti-PD-L1:TGF-ß trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer, 2022-09-14

• Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial, 2022-06-03

• Impact of Hypofractionated and Standard Fractionated Chemoradiation Prior to Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma, 2016-05-31

• Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients, 2022-12-06

• Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA, 2019-07-30

• GRP78 Expression and Prognostic Significance in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Therapy Verse Surgery First, 2021-08-18

• Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation, 2015-12-11

• Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib, 2021-04-13

• Perioperative Nivolumab Monotherapy versus Nivolumab Plus Ipilimumab in Resectable Hepatocellular Carcinoma: a randomised, open-label, phase 2 trial, 2022-01-20

• Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma, 2015-05-19

• The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy, 2015-09-08

• Prognostic Significance of New AJCC Tumor Stage in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Therapy, 2017-05-26

• A Phase I Study of Hepatic Arterial Infusion of Nab-Paclitaxel in Combination with Intravenous Gemcitabine and Bevacizumab for Patients with Advanced Cancers and Predominant Liver Metastases, 2013-02-03

• Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma, 2022-10-06

• Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study, 2020-12-05